Mohamed Genead
Directeur Général chez Aviceda Therapeutics, Inc.
Postes actifs de Mohamed Genead
Sociétés | Poste | Début | Fin |
---|---|---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
Fondateur | - | - | |
President | - | - | |
Secrétaire Général | - | - | |
Treasurer | - | - | |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Directeur Général | - | - |
Président | - | - | |
Directeur Financier/CFO | - | - | |
President | - | - | |
Secrétaire Général | - | - |
Historique de carrière de Mohamed Genead
Anciens postes connus de Mohamed Genead
Sociétés | Poste | Début | Fin |
---|---|---|---|
GENSIGHT BIOLOGICS S.A. | Directeur Technique/Scientifique/R&D | 01/05/2017 | 01/11/2017 |
University of Illinois | Corporate Officer/Principal | - | - |
OCUGEN, INC. | Directeur Technique/Scientifique/R&D | - | - |
Statistiques
Internationale
Etats-Unis | 5 |
France | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Chief Executive Officer | 2 |
President | 2 |
Sectorielle
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
GENSIGHT BIOLOGICS S.A. | Health Technology |
OCUGEN, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Health Technology |
- Bourse
- Insiders
- Mohamed Genead
- Expérience